These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11053677)

  • 1. Common gene variants, mortality and extreme longevity in humans.
    Heijmans BT; Westendorp RG; Slagboom PE
    Exp Gerontol; 2000 Sep; 35(6-7):865-77. PubMed ID: 11053677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the apo E/apo C-I, angiotensin converting enzyme and methylenetetrahydrofolate reductase genes as candidates affecting human longevity.
    Galinsky D; Tysoe C; Brayne CE; Easton DF; Huppert FA; Dening TR; Paykel ES; Rubinsztein DC
    Atherosclerosis; 1997 Mar; 129(2):177-83. PubMed ID: 9105559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MTHFR C677T, APOE, and PON55 gene polymorphisms show relevant interactions with cardiovascular risk factors.
    Murphy MM; Vilella E; Ceruelo S; Figuera L; Sanchez M; Camps J; Cuco G; Ferré N; Labad A; Tasevska N; Arija V; Joven J; Fernandez-Ballart J
    Clin Chem; 2002 Feb; 48(2):372-5. PubMed ID: 11805025
    [No Abstract]   [Full Text] [Related]  

  • 4. [Role of polymorphic variants of the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene in the pathogenesis of cardiovascular diseases].
    Spiridonova MG; Stepanov VA; Puzyrev VP
    Klin Med (Mosk); 2001; 79(2):10-6. PubMed ID: 11419077
    [No Abstract]   [Full Text] [Related]  

  • 5. Reduced frequency of the thermolabile methylenetetrahydrofolate reductase genotype in the elderly.
    Kluijtmans LA; Whitehead AS
    Atherosclerosis; 1999 Oct; 146(2):395-7. PubMed ID: 10532696
    [No Abstract]   [Full Text] [Related]  

  • 6. Factor V G1691A, apo E4 allele, hyperhomocysteinemia and MTHFR C677T in a young patient with myocardial infarction.
    Assanelli D; Ferrari R; Bollani G; Ettori F; Bonetti P; Bersatti F; Archetti S; Ruggeri G; Bonanome A; Martini G
    Thromb Haemost; 1999 Sep; 82(3):1196. PubMed ID: 10494787
    [No Abstract]   [Full Text] [Related]  

  • 7. Genetic predisposition to hyperhomocysteinemia: deficiency of methylenetetrahydrofolate reductase (MTHFR).
    Rozen R
    Thromb Haemost; 1997 Jul; 78(1):523-6. PubMed ID: 9198208
    [No Abstract]   [Full Text] [Related]  

  • 8. [Is the thermolabile variant of methylenetetrahydrofolate reductase a risk factor of arterial and venous thrombosis?].
    Trillot N; Jude B
    Rev Med Interne; 1997; 18 Suppl 6():657s-659s. PubMed ID: 9515147
    [No Abstract]   [Full Text] [Related]  

  • 9. [Genetic risk factor for the onset and progression of diabetic complication].
    Nakajima K; Tanaka Y
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():95-101. PubMed ID: 12430213
    [No Abstract]   [Full Text] [Related]  

  • 10. Frequency of factor V, prothrombin and methylenetetrahydrofolate reductase gene variants in preeclampsia.
    D'Elia AV; Driul L; Giacomello R; Colaone R; Fabbro D; Di Leonardo C; Florio P; Petraglia F; Marchesoni D; Damante G
    Gynecol Obstet Invest; 2002; 53(2):84-7. PubMed ID: 11961379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetics of methylenetetrahydrofolate reductase deficiency.
    Rozen R
    J Inherit Metab Dis; 1996; 19(5):589-94. PubMed ID: 8892013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the polymorphic genes apolipoprotein E and methylene- tetrahydrofolate reductase in the development of dementia of the Alzheimer type.
    Regland B; Blennow K; Germgård T; Koch-Schmidt AC; Gottfries CG
    Dement Geriatr Cogn Disord; 1999; 10(4):245-51. PubMed ID: 10364640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetics of preeclampsia: what are the challenges?
    Bernard N; Giguère Y
    J Obstet Gynaecol Can; 2003 Jul; 25(7):578-85. PubMed ID: 12851670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylenetetrahydrofolate reductase genotype does not play a role in multiple myeloma pathogenesis.
    González-Fraile MI; García-Sanz R; Mateos MV; Balanzategui A; González M; Váquez L; San Miguel JF
    Br J Haematol; 2002 Jun; 117(4):890-2. PubMed ID: 12060127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A common mutation of the methylenetetrahydrofolate reductase gene as a risk factor for diabetic nephropathy.
    Odawara M; Yamashita K
    Diabetologia; 1999 May; 42(5):631-2. PubMed ID: 10333059
    [No Abstract]   [Full Text] [Related]  

  • 16. Homocysteine, apolipoproteine E and methylenetetrahydrofolate reductase in Alzheimer's disease and mild cognitive impairment.
    Religa D; Styczynska M; Peplonska B; Gabryelewicz T; Pfeffer A; Chodakowska M; Luczywek E; Wasiak B; Stepien K; Golebiowski M; Winblad B; Barcikowska M
    Dement Geriatr Cogn Disord; 2003; 16(2):64-70. PubMed ID: 12784029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MTHFR association with arteriosclerotic vascular disease?
    Fletcher O; Kessling AM
    Hum Genet; 1998 Jul; 103(1):11-21. PubMed ID: 9737770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A common methylenetetrahydrofolate reductase gene mutation and longevity.
    Brattström L; Zhang Y; Hurtig M; Refsum H; Ostensson S; Fransson L; Jonés K; Landgren F; Brudin L; Ueland PM
    Atherosclerosis; 1998 Dec; 141(2):315-9. PubMed ID: 9862180
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re: "Maternal vitamin use, genetic variation of infant methylenetetrahydrofolate reductase, and risk for spina bifida".
    Botto LD; Mulinare J
    Am J Epidemiol; 1999 Aug; 150(3):323-4. PubMed ID: 10430239
    [No Abstract]   [Full Text] [Related]  

  • 20. Methylenetetrahydrofolate reductase 677CC normal genotype may protect against multiple myeloma.
    Yanamandra K; Bocchini JA; Thurmon TF
    Br J Haematol; 2003 Mar; 120(6):1094-5; author reply 1095-6. PubMed ID: 12648087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.